Qube Research & Technologies Ltd

Position in AZN — Astrazeneca PLC

CIK 1729829 LONDON, X0

Back to AZN Full portfolio

Position in AZN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$71,197,190

-$4,150,316 QoQ

Shares Held

375,473

-1.7% QoQ

Ownership

0.024%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#145

of 1,462 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AZN Over Time

Shares Held

Position Value (USD)

Derivatives in AZN

reported options exposure · as of Jun 30, 2026

CallValue

$1,166,163

CallShares

6,150

PutValue

$142,215

PutShares

750

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $1,498,530,307 across 11 Drug Manufacturers - General names. AZN ranks #6 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	346,498	$415,600,130
2	GILD	Gilead Sciences, Inc.	3,086,166	$389,906,212
3	JNJ	Johnson & Johnson	752,337	$191,071,027
4	BMY	Bristol Myers Squibb Co	3,093,958	$178,273,859
5	MRK	Merck & Co., Inc.	1,044,210	$134,180,985
6	AZN	Astrazeneca PLC This page	375,473	$71,197,190
7	GSK	GSK plc	1,078,767	$56,548,966
8	SNY	Sanofi	634,794	$27,080,312

All Filings in AZN

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,166,163	6,150	-33.5%	Call	Sole	2026-08-14
2026-06-30	$71,197,190	375,473	-1.7%	Shares	Sole	2026-08-14
2026-06-30	$142,215	750	-87.2%	Put	Sole	2026-08-14
2026-03-31	$1,824,285	9,250	—	Call	Sole	2026-05-15
2026-03-31	$1,153,737	5,850	—	Put	Sole	2026-05-15
2026-03-31	$75,347,506	382,048	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.